Lethal toxicities after capecitabine intake in a previously 5-FU-treated patient: why dose matters with dihydropryimidine dehydrogenase deficiency

authors

Gbeto Crescent
Quaranta Sylvie
Mari Roxane
Fanciullino Raphaelle
Roche Catherine
Nahon Sophie
Solas Caroline
Ouafik L’houcine
Lacarelle Bruno
Allegre Thierry
Ciccolini Joseph

document type

ART

more information